Rate My Professor Lor Huai

Chong's research centers on developing multi-scale tissue models and organ-on-chip platforms to mimic complex biological interactions and translate them into scalable systems for disease modeling, drug testing, and cancer research. As Primary Chief Investigator, she leads projects such as the Development of a 3D Metastatic Breast Cancer-on-Chip Model for Evaluating Liposome-Based Drug Delivery Systems (2023–2025), Organ-on-Chip: A Potential Biophysical Modeling Tool to Modulate Cancer Metastasis Targeted-Drug Development (2022–2026), and Development of an Immunoassay-on-a-Chip for Evaluating T-Cell and NK-Cell Infiltration in Cancer Immunotherapy (2025–2027). Key publications include 'Integration of a microfluidic multicellular coculture array with machine learning analysis to predict adverse cutaneous drug reactions' (Lab on a Chip, 2022), 'A liver-immune coculture array for predicting systemic drug-induced skin sensitization' (Lab on a Chip, 2018), 'Self-aligning Tetris-Like (TILE) modular microfluidic platform for mimicking multi-organ interactions' (Lab on a Chip, 2019), and 'A pump-free microfluidic 3D perfusion platform for the efficient differentiation of human hepatocyte-like cells' (Biotechnology and Bioengineering, 2017). She coordinates the teaching unit PHR1031 How The Body Works, supervises PhD students on organ-on-chip applications in cancer metastasis and gut microbiota-colorectal cancer interactions, and contributes to UN Sustainable Development Goal 3: Good Health and Well-being.